http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2021, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 26 Jul 2018 09:30:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/I-Mab+Biopharma+and+ABL+Bio+Announce+Global+Collaboration+on+Innovative+Bispecific+Antibodies/14436644.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/I-Mab+Biopharma+and+ABL+Bio+Announce+Global+Collaboration+on+Innovative+Bispecific+Antibodies/14436644.html for the full story. http://www.streetinsider.com/Press+Releases/I-Mab+Biopharma+and+ABL+Bio+Announce+Global+Collaboration+on+Innovative+Bispecific+Antibodies/14436644.html Thu, 26 Jul 2018 09:30:00 -0500 A.25373232 MOR MOR MPSYY http://www.streetinsider.com/Press+Releases/I-Mab+Biopharma+and+ABL+Bio+Announce+Global+Collaboration+on+Innovative+Bispecific+Antibodies/14436644.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/I-Mab+Biopharma+and+ABL+Bio+Announce+Global+Collaboration+on+Innovative+Bispecific+Antibodies/14436644.html for the full story. http://www.streetinsider.com/Press+Releases/I-Mab+Biopharma+and+ABL+Bio+Announce+Global+Collaboration+on+Innovative+Bispecific+Antibodies/14436644.html Thu, 26 Jul 2018 09:30:00 -0500 A.25373232 MOR MOR MPSYY http://www.streetinsider.com/Press+Releases/I-Mab+Biopharma+and+ABL+Bio+Announce+Global+Collaboration+on+Innovative+Bispecific+Antibodies/14436644.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/I-Mab+Biopharma+and+ABL+Bio+Announce+Global+Collaboration+on+Innovative+Bispecific+Antibodies/14436644.html for the full story. http://www.streetinsider.com/Press+Releases/I-Mab+Biopharma+and+ABL+Bio+Announce+Global+Collaboration+on+Innovative+Bispecific+Antibodies/14436644.html Thu, 26 Jul 2018 09:30:00 -0500 A.25373232 MOR MOR MPSYY http://www.streetinsider.com/Press+Releases/I-Mab+Biopharma+and+ABL+Bio+Announce+Global+Collaboration+on+Innovative+Bispecific+Antibodies/14436644.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/I-Mab+Biopharma+and+ABL+Bio+Announce+Global+Collaboration+on+Innovative+Bispecific+Antibodies/14436644.html for the full story. http://www.streetinsider.com/Press+Releases/I-Mab+Biopharma+and+ABL+Bio+Announce+Global+Collaboration+on+Innovative+Bispecific+Antibodies/14436644.html Thu, 26 Jul 2018 09:30:00 -0500 A.25373232 MOR MOR MPSYY http://www.streetinsider.com/Press+Releases/Nasdaq+Welcomes+MorphoSys+AG+%28Nasdaq%3A+MOR%29+to+The+Nasdaq+Stock+Market/14074985.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Nasdaq+Welcomes+MorphoSys+AG+%28Nasdaq%3A+MOR%29+to+The+Nasdaq+Stock+Market/14074985.html for the full story. http://www.streetinsider.com/Press+Releases/Nasdaq+Welcomes+MorphoSys+AG+%28Nasdaq%3A+MOR%29+to+The+Nasdaq+Stock+Market/14074985.html Thu, 19 Apr 2018 16:24:00 -0500 MOR MPSYY NDAQ http://www.streetinsider.com/Press+Releases/Nasdaq+Welcomes+MorphoSys+AG+%28Nasdaq%3A+MOR%29+to+The+Nasdaq+Stock+Market/14074985.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Nasdaq+Welcomes+MorphoSys+AG+%28Nasdaq%3A+MOR%29+to+The+Nasdaq+Stock+Market/14074985.html for the full story. http://www.streetinsider.com/Press+Releases/Nasdaq+Welcomes+MorphoSys+AG+%28Nasdaq%3A+MOR%29+to+The+Nasdaq+Stock+Market/14074985.html Thu, 19 Apr 2018 16:24:00 -0500 MOR MPSYY NDAQ http://www.streetinsider.com/Press+Releases/Nasdaq+Welcomes+MorphoSys+AG+%28Nasdaq%3A+MOR%29+to+The+Nasdaq+Stock+Market/14074985.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Nasdaq+Welcomes+MorphoSys+AG+%28Nasdaq%3A+MOR%29+to+The+Nasdaq+Stock+Market/14074985.html for the full story. http://www.streetinsider.com/Press+Releases/Nasdaq+Welcomes+MorphoSys+AG+%28Nasdaq%3A+MOR%29+to+The+Nasdaq+Stock+Market/14074985.html Thu, 19 Apr 2018 16:24:00 -0500 MOR MPSYY NDAQ http://www.streetinsider.com/Press+Releases/I-Mab+Biopharma+Partners+with+MorphoSys+on+Cancer+Investigational+Medicine/13558186.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/I-Mab+Biopharma+Partners+with+MorphoSys+on+Cancer+Investigational+Medicine/13558186.html for the full story. http://www.streetinsider.com/Press+Releases/I-Mab+Biopharma+Partners+with+MorphoSys+on+Cancer+Investigational+Medicine/13558186.html Fri, 01 Dec 2017 02:55:00 -0500 MOR MOR MPSYY http://www.streetinsider.com/Press+Releases/I-Mab+Biopharma+Partners+with+MorphoSys+on+Cancer+Investigational+Medicine/13558186.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/I-Mab+Biopharma+Partners+with+MorphoSys+on+Cancer+Investigational+Medicine/13558186.html for the full story. http://www.streetinsider.com/Press+Releases/I-Mab+Biopharma+Partners+with+MorphoSys+on+Cancer+Investigational+Medicine/13558186.html Fri, 01 Dec 2017 02:55:00 -0500 MOR MOR MPSYY http://www.streetinsider.com/Press+Releases/I-Mab+Biopharma+Partners+with+MorphoSys+on+Cancer+Investigational+Medicine/13558186.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/I-Mab+Biopharma+Partners+with+MorphoSys+on+Cancer+Investigational+Medicine/13558186.html for the full story. http://www.streetinsider.com/Press+Releases/I-Mab+Biopharma+Partners+with+MorphoSys+on+Cancer+Investigational+Medicine/13558186.html Fri, 01 Dec 2017 02:55:00 -0500 MOR MOR MPSYY http://www.streetinsider.com/Press+Releases/MorphoSys+Partner+to+Start+Phase+2+Trial+with+Bimagrumab+in+Obese+Patients+with+Type+2+Diabetes/12418815.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MorphoSys+Partner+to+Start+Phase+2+Trial+with+Bimagrumab+in+Obese+Patients+with+Type+2+Diabetes/12418815.html for the full story. http://www.streetinsider.com/Press+Releases/MorphoSys+Partner+to+Start+Phase+2+Trial+with+Bimagrumab+in+Obese+Patients+with+Type+2+Diabetes/12418815.html Thu, 12 Jan 2017 04:30:00 -0500 MOR MPSYY http://www.streetinsider.com/Press+Releases/MorphoSys+Partner+to+Start+Phase+2+Trial+with+Bimagrumab+in+Obese+Patients+with+Type+2+Diabetes/12418815.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MorphoSys+Partner+to+Start+Phase+2+Trial+with+Bimagrumab+in+Obese+Patients+with+Type+2+Diabetes/12418815.html for the full story. http://www.streetinsider.com/Press+Releases/MorphoSys+Partner+to+Start+Phase+2+Trial+with+Bimagrumab+in+Obese+Patients+with+Type+2+Diabetes/12418815.html Thu, 12 Jan 2017 04:30:00 -0500 MOR MPSYY http://www.streetinsider.com/Press+Releases/Dr.+Malte+Peters+to+Become+New+Chief+Development+Officer+of+MorphoSys+AG/12395005.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Dr.+Malte+Peters+to+Become+New+Chief+Development+Officer+of+MorphoSys+AG/12395005.html for the full story. http://www.streetinsider.com/Press+Releases/Dr.+Malte+Peters+to+Become+New+Chief+Development+Officer+of+MorphoSys+AG/12395005.html Thu, 05 Jan 2017 01:55:00 -0500 MOR MOR MPSYY http://www.streetinsider.com/Press+Releases/Dr.+Malte+Peters+to+Become+New+Chief+Development+Officer+of+MorphoSys+AG/12395005.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Dr.+Malte+Peters+to+Become+New+Chief+Development+Officer+of+MorphoSys+AG/12395005.html for the full story. http://www.streetinsider.com/Press+Releases/Dr.+Malte+Peters+to+Become+New+Chief+Development+Officer+of+MorphoSys+AG/12395005.html Thu, 05 Jan 2017 01:55:00 -0500 MOR MOR MPSYY http://www.streetinsider.com/Press+Releases/Dr.+Malte+Peters+to+Become+New+Chief+Development+Officer+of+MorphoSys+AG/12395005.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Dr.+Malte+Peters+to+Become+New+Chief+Development+Officer+of+MorphoSys+AG/12395005.html for the full story. http://www.streetinsider.com/Press+Releases/Dr.+Malte+Peters+to+Become+New+Chief+Development+Officer+of+MorphoSys+AG/12395005.html Thu, 05 Jan 2017 01:55:00 -0500 MOR MOR MPSYY http://www.streetinsider.com/Press+Releases/MorphoSys+to+Present+at+Upcoming+Investor+Conferences/12383868.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MorphoSys+to+Present+at+Upcoming+Investor+Conferences/12383868.html for the full story. http://www.streetinsider.com/Press+Releases/MorphoSys+to+Present+at+Upcoming+Investor+Conferences/12383868.html Tue, 03 Jan 2017 08:33:00 -0500 MOR MPSYY http://www.streetinsider.com/Press+Releases/MorphoSys+to+Present+at+Upcoming+Investor+Conferences/12383868.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MorphoSys+to+Present+at+Upcoming+Investor+Conferences/12383868.html for the full story. http://www.streetinsider.com/Press+Releases/MorphoSys+to+Present+at+Upcoming+Investor+Conferences/12383868.html Tue, 03 Jan 2017 08:33:00 -0500 MOR MPSYY http://www.streetinsider.com/Press+Releases/MorphoSys+Starts+Phase+2+Trial+of+MOR208+in+Combination+with+Idelalisib+in+Patients+with+Relapsed+or+Refractory+CLL+or+SLL+Previously+Treated+with+a+BTK+Inhibitor/12335508.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MorphoSys+Starts+Phase+2+Trial+of+MOR208+in+Combination+with+Idelalisib+in+Patients+with+Relapsed+or+Refractory+CLL+or+SLL+Previously+Treated+with+a+BTK+Inhibitor/12335508.html for the full story. http://www.streetinsider.com/Press+Releases/MorphoSys+Starts+Phase+2+Trial+of+MOR208+in+Combination+with+Idelalisib+in+Patients+with+Relapsed+or+Refractory+CLL+or+SLL+Previously+Treated+with+a+BTK+Inhibitor/12335508.html Tue, 13 Dec 2016 01:37:00 -0500 A.14972944 MOR MPSYY http://www.streetinsider.com/Press+Releases/MorphoSys+Starts+Phase+2+Trial+of+MOR208+in+Combination+with+Idelalisib+in+Patients+with+Relapsed+or+Refractory+CLL+or+SLL+Previously+Treated+with+a+BTK+Inhibitor/12335508.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MorphoSys+Starts+Phase+2+Trial+of+MOR208+in+Combination+with+Idelalisib+in+Patients+with+Relapsed+or+Refractory+CLL+or+SLL+Previously+Treated+with+a+BTK+Inhibitor/12335508.html for the full story. http://www.streetinsider.com/Press+Releases/MorphoSys+Starts+Phase+2+Trial+of+MOR208+in+Combination+with+Idelalisib+in+Patients+with+Relapsed+or+Refractory+CLL+or+SLL+Previously+Treated+with+a+BTK+Inhibitor/12335508.html Tue, 13 Dec 2016 01:37:00 -0500 A.14972944 MOR MPSYY http://www.streetinsider.com/Press+Releases/MorphoSys+Starts+Phase+2+Trial+of+MOR208+in+Combination+with+Idelalisib+in+Patients+with+Relapsed+or+Refractory+CLL+or+SLL+Previously+Treated+with+a+BTK+Inhibitor/12335508.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MorphoSys+Starts+Phase+2+Trial+of+MOR208+in+Combination+with+Idelalisib+in+Patients+with+Relapsed+or+Refractory+CLL+or+SLL+Previously+Treated+with+a+BTK+Inhibitor/12335508.html for the full story. http://www.streetinsider.com/Press+Releases/MorphoSys+Starts+Phase+2+Trial+of+MOR208+in+Combination+with+Idelalisib+in+Patients+with+Relapsed+or+Refractory+CLL+or+SLL+Previously+Treated+with+a+BTK+Inhibitor/12335508.html Tue, 13 Dec 2016 01:37:00 -0500 A.14972944 MOR MPSYY http://www.streetinsider.com/Press+Releases/MorphoSys+Presents+Updated+Clinical+Results+for+Anti-CD38+Antibody+MOR202+at+ASH+2016/12313637.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MorphoSys+Presents+Updated+Clinical+Results+for+Anti-CD38+Antibody+MOR202+at+ASH+2016/12313637.html for the full story. http://www.streetinsider.com/Press+Releases/MorphoSys+Presents+Updated+Clinical+Results+for+Anti-CD38+Antibody+MOR202+at+ASH+2016/12313637.html Tue, 06 Dec 2016 01:42:00 -0500 A.32437804 MOR MPSYY http://www.streetinsider.com/Press+Releases/MorphoSys+Presents+Updated+Clinical+Results+for+Anti-CD38+Antibody+MOR202+at+ASH+2016/12313637.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MorphoSys+Presents+Updated+Clinical+Results+for+Anti-CD38+Antibody+MOR202+at+ASH+2016/12313637.html for the full story. http://www.streetinsider.com/Press+Releases/MorphoSys+Presents+Updated+Clinical+Results+for+Anti-CD38+Antibody+MOR202+at+ASH+2016/12313637.html Tue, 06 Dec 2016 01:42:00 -0500 A.32437804 MOR MPSYY http://www.streetinsider.com/Press+Releases/MorphoSys+Presents+Updated+Clinical+Results+for+Anti-CD38+Antibody+MOR202+at+ASH+2016/12313637.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MorphoSys+Presents+Updated+Clinical+Results+for+Anti-CD38+Antibody+MOR202+at+ASH+2016/12313637.html for the full story. http://www.streetinsider.com/Press+Releases/MorphoSys+Presents+Updated+Clinical+Results+for+Anti-CD38+Antibody+MOR202+at+ASH+2016/12313637.html Tue, 06 Dec 2016 01:42:00 -0500 A.32437804 MOR MPSYY http://www.streetinsider.com/Press+Releases/MorphoSys+Presents+Updated+Clinical+Data+for+Blood+Cancer+Candidate+MOR208+in+NHL+and+CLL+at+ASH+2016+Conference/12313636.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MorphoSys+Presents+Updated+Clinical+Data+for+Blood+Cancer+Candidate+MOR208+in+NHL+and+CLL+at+ASH+2016+Conference/12313636.html for the full story. http://www.streetinsider.com/Press+Releases/MorphoSys+Presents+Updated+Clinical+Data+for+Blood+Cancer+Candidate+MOR208+in+NHL+and+CLL+at+ASH+2016+Conference/12313636.html Tue, 06 Dec 2016 01:39:00 -0500 A.02960939 A.14972944 A.32437804 MOR MPSYY http://www.streetinsider.com/Press+Releases/MorphoSys+Presents+Updated+Clinical+Data+for+Blood+Cancer+Candidate+MOR208+in+NHL+and+CLL+at+ASH+2016+Conference/12313636.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MorphoSys+Presents+Updated+Clinical+Data+for+Blood+Cancer+Candidate+MOR208+in+NHL+and+CLL+at+ASH+2016+Conference/12313636.html for the full story. http://www.streetinsider.com/Press+Releases/MorphoSys+Presents+Updated+Clinical+Data+for+Blood+Cancer+Candidate+MOR208+in+NHL+and+CLL+at+ASH+2016+Conference/12313636.html Tue, 06 Dec 2016 01:39:00 -0500 A.02960939 A.14972944 A.32437804 MOR MPSYY